Please try another search
For the nine months ended 30 September 2016, Canexus Corp revenues decreased less than 1% to C$422.5M. Net income before extraordinary items decreased 59% to C$19.9M. Revenues reflect North America Sodium Chlorate; segment increase of 4% to C$206.6M, Canada segment increase of 10% to C$168.3M, also reflect North America Chlor-alkali; segment decrease of 3% to C$142.5M, South America-Sodium chlorate & chloralkali segment decrease of 5% to C$73.6M.
Period Ending: | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 |
---|---|---|---|---|
Total Revenue | 142.02 | 135.95 | 144.53 | 139.54 |
Gross Profit | 53.01 | 51.36 | 55.24 | 50.95 |
Operating Income | 14.57 | 10.19 | 14.36 | -47.21 |
Net Income | -0.6 | 3.96 | 16.52 | -45.03 |
Period Ending: | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 |
---|---|---|---|---|
Total Assets | 719.35 | 709.86 | 709.24 | 710.59 |
Total Liabilities | 746.83 | 736.43 | 735.86 | 746.88 |
Total Equity | -27.49 | -26.57 | -26.62 | -36.28 |
Period Ending: | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 |
---|---|---|---|---|
Period Length: | 9 Months | 6 Months | 3 Months | 12 Months |
Cash From Operating Activities | 30.9 | 10.85 | 5.49 | 65.1 |
Cash From Investing Activities | -15.16 | -9.91 | -6.29 | 11.16 |
Cash From Financing Activities | -9.06 | -5.36 | -2.73 | -70.81 |
Net Change in Cash | 5.61 | -5.77 | -4.76 | 5.5 |
Unlock access to over 1000 metrics with InvestingPro
View advanced insights on financial statements, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review